跳至主要内容
临床试验/ACTRN12618001326280
ACTRN12618001326280招募中未知

Investigating the efficacy of continuous positive airway pressure (CPAP) in patients receiving radiotherapy treatment for centrally located lung cancers.

Auckland City Hospital0 个研究点目标入组 20 人开始时间: 2018年8月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • Patients who meet the following criteria will be eligible:
  • -Aged 16 years or older.
  • - Diagnosed with centrally located lung tumour, defined as within 2cm in all directions of any mediastinal critical structure, including the bronchial tree, esophagus, heart, brachial plexus, major vessels, spinal cord, phrenic nerve and recurrent laryngeal nerve.
  • - Prescribed (by an Radiation Oncology) a Radiotherapy Treatment of 60Gy in 8 fractions (SABR) or 48Gy in 12 fractions (hypofractionation).
  • - Meets the current departmental inclusion criteria for a treatment prescription of 60Gy in 8 fractions (SABR) or 48Gy in 12 fractions (hypofractionation).

排除标准

  • Patients that have significant comorbidities that may result in them not tolerating treatment with CPAP (recent surgery, respiratory conditions, inappropriate age, and disabilities).
  • Patients who are unable to provide informed consent or who refuse to use CPAP.

研究者

相似试验